Platelet Adhesion under Flow

References

• Aarts PA, van den Broek SA, Prins GW, Kuiken GDC, Sixma JJ, Heethaar RM. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis 1988; 8: 819–824
   PubMedGoogle Scholar
• Adams J, Lawler J. The thrombospondin family. Curr Biol 1993; 3: 188–190
   PubMed Web of Science ®Google Scholar
• Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000; 96: 3322–3328
   PubMed Web of Science ®Google Scholar
• Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nat Med 2002; 8: 247–252
   PubMed Web of Science ®Google Scholar
• Andrews RJ, Booth WJ, Bendall LJ, Brendt MC. The amino acid sequence glutamine-628 to valine-646 within the A1 repeat domain mediates binding of von Willebrand factor to bovine brain sulfatides and equine tendon collagen. Platelets 1995; 6: 245–251
   Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003; 35: 1170–1174
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlback B, Carmeliet P. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 7: 215–221
   PubMed Web of Science ®Google Scholar
• Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, Lopez JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002; 99: 3971–3977
   PubMed Web of Science ®Google Scholar
• Asch E, Podack E. Vitronectin binds to activated human platelets and plays a role in patelet aggregation. J Clin Invest 1990; 85: 1372–1378
   PubMed Web of Science ®Google Scholar
• Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Atertio Thromb Vasc Biol 2005; 25: 1280–1286
   PubMed Web of Science ®Google Scholar
• Baruch D, Denis C, Marteaux C, Schoevaert D, Coulombel L, Meyer D. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion. Blood 1991; 77: 519–527
   PubMed Web of Science ®Google Scholar
• Basmadjian D. The effect of flow and mass transport in thrombogenesis. Ann Biomed Eng 1990; 18: 685–709
   PubMed Web of Science ®Google Scholar
• Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5: 167–179
   PubMed Web of Science ®Google Scholar
• Beumer S, Heijnen HF, Ijsseldijk MJ, Orlando E, de Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. Blood 1995; 86: 3452–3460
   Google Scholar
• Bluestein D, Niu L, Schoephoerster RT, Dewanjee MK. Fluid mechanics of arterial stenosis: relationship to the development of mural thrombus. Ann Biomed Eng 1997; 25: 344–356
   PubMed Web of Science ®Google Scholar
• Bonnefoy A, Romijn RA, Vandervoort PA, Van Rompaey I, Vermylen J, Hoylaerts MF. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Haemost 2006; 4: 2151–2161
   PubMed Web of Science ®Google Scholar
• Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
   PubMed Web of Science ®Google Scholar
• Borthakur G, Cruz MA, Dong JF, McIntire L, Li F, Lopez JA, Thiagarajan P. Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J Thromb Haemost 2003; 1: 1288–1295
   Google Scholar
• Bowie EJ, Solberg LA, Jr, Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 1986; 78: 26–30
   PubMed Web of Science ®Google Scholar
• Castillo R, Monteagudo J, Escolar G, Ordinas A, Magallon M, Villar JM. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients. Blood 1991; 77: 1901–1905
   PubMed Web of Science ®Google Scholar
• Celikel R, Ruggeri ZM, Varughese KI. von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nat Struct Biol 2000; 7: 881–884
   Google Scholar
• Chauhan AK, Kisucka J, Cozzi MR, Walsh MT, Moretti FA, Battiston M, Mazzucato M, De Marco L, Baralle FE, Wagner DD, Muro AF. Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler Thromb Vasc Biol 2008; 28: 296–301
   Google Scholar
• Chauhan AK, Motto DG, Lamb CB, Bergmeier W, Dockal M, Plaimauer B, Scheiflinger F, Ginsburg D, Wagner DD. Systemic antithrombotic effects of ADAMTS13. J Exp Med 2006; 203: 767–776
   PubMed Web of Science ®Google Scholar
• Cheli Y, Jensen P, Marchese P, Habart D, Wiltshire T, Cooke M, Fernandez JA, Ware J, Ruggeri ZM, Kunicki TJ. The modifier of hemostasis (mh) locus on mouse chromosome 4 controls in vivo hemostasis of GP6−/ − mice. Blood 2008; 111: 1266–1273
   PubMed Web of Science ®Google Scholar
• Chen S, Springer TA. Selectin receptor-ligand bonds: formation limited by shear rate and dissociation governed by the Bell model. Proc Natl Acad Sci USA 2001; 98: 950–955
   PubMed Web of Science ®Google Scholar
• Chiang TM, Rinaldy A, Kang AH. Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen. J Biol Chem 1997; 100: 514–529
   Google Scholar
• Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR. ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood 2007; 109: 1998–2000
   PubMed Web of Science ®Google Scholar
• Cho J, Mosher DF. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 2006; 108: 2229–2236
   PubMed Web of Science ®Google Scholar
• Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006; 4: 1461–1469
   PubMed Web of Science ®Google Scholar
• Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong JF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem 2007; 282: 35604–35611
   PubMed Web of Science ®Google Scholar
• Christophe O, Obert B, Meyer D, Girma JP. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood 1991; 78: 2310–2317
   Google Scholar
• Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75–83
   PubMed Web of Science ®Google Scholar
• Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325–338
   PubMed Web of Science ®Google Scholar
• Colombatti A, Bonaldo P. The superfamily of proteins with von Willebrand factor type A-like domains: One theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 1991; 77: 2305–2315
   PubMed Web of Science ®Google Scholar
• Dejana E, Lampugnani MG, Giorgi M, Gaboli M, Federici AB, Ruggeri ZM. von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism. J Cell Biol 1989; 109: 367–375
   PubMed Web of Science ®Google Scholar
• Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe O, Meyer D. Localization on von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Atertio Thromb Vasc Biol 1993; 13: 398–406
   PubMedGoogle Scholar
• Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIa von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 6306–6310
   PubMed Web of Science ®Google Scholar
• Dent JA, Galbusera M, Ruggeri ZM. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991; 88: 774–782
   PubMed Web of Science ®Google Scholar
• Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 1993; 82: 491–496
   PubMedGoogle Scholar
• Doggett TA, Girdhar G, Lawshe A, Schmidtke DW, Laurenzi IJ, Diamond SL, Diacovo TG. Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIbα-vWF tether bond. Biophys J 2002; 83: 194–205
   PubMed Web of Science ®Google Scholar
• Donadelli R, Orje JN, Capoferri C, Remuzzi G, Ruggeri ZM. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS-13 in flowing blood. Blood 2006; 107: 1943–1950
   PubMedGoogle Scholar
• Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultra-large von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033–4039
   PubMed Web of Science ®Google Scholar
• Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem 2004; 279: 23327–22334
   PubMedGoogle Scholar
• Eckstein EC, Belgacem F. Model of platelet transport in flowing blood with drift and diffusion terms. Biophys J 1991; 60: 53–69
   PubMed Web of Science ®Google Scholar
• Eckstein EC, Tilles AW, Millero Iii FJ. Conditions for the occurrence of large near-wall excesses of small particles during blood flow. Microvasc Res 1988; 36: 31–39
   PubMedGoogle Scholar
• Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004; 2: 561–573
   PubMed Web of Science ®Google Scholar
• Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450–7454
   PubMed Web of Science ®Google Scholar
• Fretto LJ, Fowler WE, McCaslin DR, Erickson HP, McKee PA. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains. J Biol Chem 1986; 261: 15679–15689
   Google Scholar
• Fujimura Y, Titani K, Holland LZ, Roberts JR, Kostel P, Ruggeri ZM, Zimmerman TS. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 1987; 262: 1734–1739
   Google Scholar
• Fung YC. (1984). Biodynamics: Circulation. New York: Springer-Verlag.
   Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Giandomenico G, Dellas C, Czekay RP, Koschnick S, Loskutoff DJ. The leptin receptor system of human platelets. J Thromb Haemost 2005; 3: 1042–1049
   PubMed Web of Science ®Google Scholar
• Ginsberg MH, Forsyth J, Lightsey A, Chediak J, Plow EF. Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets. J Clin Invest 1983; 71: 619–624
   Google Scholar
• Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005; 17: 509–516
   PubMed Web of Science ®Google Scholar
• Ginsberg MH, Xiaoping D, O'Toole TE, Loftus JC, Plow EF. Platelet integrins. Thromb Haemost 1993; 70: 87–93
   PubMed Web of Science ®Google Scholar
• Godyna S, Diaz-Ricart M, Argraves WS. Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood 1996; 88: 2569–2577
   PubMed Web of Science ®Google Scholar
• Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemost 1986; 55: 415–435
   PubMed Web of Science ®Google Scholar
• Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479–486
   PubMed Web of Science ®Google Scholar
• Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352–23361
   PubMed Web of Science ®Google Scholar
• Goto S, Tamura N, Ishida H, Ruggeri ZM. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5’-diphosphate receptor stimulation and cyclic calcium signaling. J Am Coll Cardiol 2005; 47: 155–162
   Google Scholar
• Gould WR, Baxi SM, Schroeder R, Peng YW, Leadley RJ, Peterson JT, Perrin LA. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost 2005; 3: 733–741
   Google Scholar
• Guidetti GF, Bartolini B, Bernardi B, Tira ME, Berndt MC, Balduini C, Torti M. Binding of von Willebrand factor to the small proteoglycan decorin. FEBS Lett 2004; 574: 95–100
   Google Scholar
• Hada M, Kaminski M, Bockenstedt P, McDonagh J. Covalent crosslinking of von Willebrand factor to fibrin. Blood 1986; 68: 95–101
   PubMed Web of Science ®Google Scholar
• Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345–353
   PubMed Web of Science ®Google Scholar
• He L, Pappan LK, Grenache DG, Li Z, Tollefsen DM, Santoro SA, Zutter MM. The contributions of the α2β1 integrin to vascular thrombosis in vivo. Blood 2003; 102: 3652–3657
   PubMed Web of Science ®Google Scholar
• Hindriks G, Ijsseldijk MJW, Sonnenberg A, Sixma JJ, deGroot PG. Platelet adhesion to laminin: Role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood 1992; 79: 928–935
   PubMedGoogle Scholar
• Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 1997; 324: 185–191
   PubMed Web of Science ®Google Scholar
• Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 2002; 297: 1176–1179
   PubMed Web of Science ®Google Scholar
• Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 2005; 106: 3035–3042
   PubMed Web of Science ®Google Scholar
• Hynes RO. (1989). Fibronectins. New York: Springer-Verlag.
   Google Scholar
• Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Chisari FV, Ruggeri ZM, Guidotti LG. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 2005; 11: 1167–1169
   PubMed Web of Science ®Google Scholar
• Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, Chisari FV, Ruggeri ZM, Guidotti LG. Platelets prevent IFN-α/β-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci USA 2008; 105: 629–634
   PubMed Web of Science ®Google Scholar
• Iannacone M, Sitia G, Narvaiza I, Ruggeri ZM, Guidotti LG. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol 2007; 14: 1532–1535
   PubMed Web of Science ®Google Scholar
• Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 2007; 46: 719–726
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234–1240
   PubMed Web of Science ®Google Scholar
• Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP. Laminin stimulates spreading of platelets through integrin α6β1 dependent activation of GPVI. Blood 2006; 107: 1405–1412
   PubMed Web of Science ®Google Scholar
• Ishii T, Asuwa N. Spiraled collagen in the major blood vessels. Mod Pathol 1996; 9: 843–848
   Google Scholar
• Jagadeeswaran P, Gregory M, Day K, Cykowski M, Thattaliyath B. Zebrafish: A genetic model for hemostasis and thrombosis. J Thromb Haemost 2005; 3: 46–53
   PubMed Web of Science ®Google Scholar
• Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, Wagner DD, Graf T, Italiano JE, Jr, Shivdasani RA, von Andrian UH. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007; 317: 1767–1770
   PubMed Web of Science ®Google Scholar
• Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, Varon D, Sixma JJ, Van Aken H, Kehrel BE. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003; 17: 1490–1492
   PubMed Web of Science ®Google Scholar
• Karnis A, Mason SG. Particle motions in sheared suspensions xix. Viscoelastic media. Transact Soc Rheol 1966; 10: 571–592
   Google Scholar
• Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003; 102: 1701–1707
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533–1540
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Schafer K, Neels JG, Dellas C, Loskutoff DJ. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. Atertio Thromb Vasc Biol 2004; 24: 2196–2201
   PubMedGoogle Scholar
• Konstantinides S, Schafer K, Thinnes T, Loskutoff DJ. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 2001; 103: 576–583
   Google Scholar
• Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff D, Ruggeri ZM. Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 2006; 4: 2014–2021
   PubMed Web of Science ®Google Scholar
• Koschnick S, Konstantinides S, Schafer K, Crain K, Loskutoff DJ. Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin. J Thromb Haemost 2005; 3: 2290–2295
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Nugent DJ, Staats SJ, Orchekowski RP, Wayner EA, Carter WG. The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem 1988; 263: 4516–4519
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Rojnuckarin P, Reidy MA, Hankenson KD, Papayannopoulou T, Kaushansky K, Bornstein P. Megakaryocytes require thrombospondin-2 for normal platelet formation and function. Blood 2003; 101: 3915–3923
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Zhu Y, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998; 140: 419–430
   PubMed Web of Science ®Google Scholar
• Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 1996; 75: 950–958
   PubMed Web of Science ®Google Scholar
• Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553–1559
   PubMed Web of Science ®Google Scholar
• Levy GG, Nichols WC, Lian EC, Foroud T, McClintock JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488–494
   PubMed Web of Science ®Google Scholar
• Li Y, Choi H, Zhou Z, Nolasco L, Pownall HJ, Voorberg J, Moake JL, Dong JF. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost 2008; 6: 1135–1143
   PubMed Web of Science ®Google Scholar
• Lisman T, Raynal N, Groeneveld D, Maddox B, Peachey AR, Huizinga EG, de Groot PG, Farndale RW. A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. Blood 2006; 108: 3753–3756
   PubMedGoogle Scholar
• Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, De Gaetano G. Uraemic bleeding: role of anaemia and beneficial effect of red cell. Lancet 1982; 2: 1013–1015
   PubMed Web of Science ®Google Scholar
• Lopez-Fernandez MF, Ginsberg MH, Ruggeri ZM, Batlle J, Zimmerman TS. Multimeric structure of platelet factor VIII/von Willebrand factor. The presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood 1982; 60: 1132–1138
   Google Scholar
• Lou J, Zhu C. Flow induces loop-to-hairpin transition on the β-switch of platelet glycoprotein Ibα. Proc Natl Acad Sci USA 2008; 105: 13847–13852
   PubMed Web of Science ®Google Scholar
• Mailhac A, Badimon JJ, Fallon JT, Fernandez-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 1994; 90: 988–996
   PubMedGoogle Scholar
• Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB. The endothelial cell ecto-adpase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 1351–1360
   PubMed Web of Science ®Google Scholar
• Marshall BT, Long M, Piper JW, Yago T, McEver RP, Zhu C. Direct observation of catch bonds involving cell-adhesion molecules. Nature 2003; 423: 190–193
   PubMed Web of Science ®Google Scholar
• Mazzucato M, Pradella P, Cozzi MR, De Marco L, Ruggeri ZM. Sequential cytoplasmic calcium signals in a two-stage platelet activation process induced by the glycoprotein Ibα mechanoreceptor. Blood 2002; 100: 2793–2800
   PubMed Web of Science ®Google Scholar
• Mazzucato M, Spessotto P, Masotti A, De Appollonia L, Cozzi MR, Yoshioka A, Perris R, Colombatti A, De Marco L. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. J Biol Chem 1999; 274: 3033–3041
   Google Scholar
• McKeown L, Vail M, Williams S, Kramer W, Hansmann K, Gralnick H. Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood 1994; 83: 2866–2871
   PubMedGoogle Scholar
• Meseguer J, Esteban MA, Rodriguez A. Are thrombocytes and platelets true phagocytes?. Microsc Res Tech 2002; 57: 491–497
   Google Scholar
• Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589–600
   PubMed Web of Science ®Google Scholar
• Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azacar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432–1435
   PubMed Web of Science ®Google Scholar
• Mody NA, King MR. Platelet adhesive dynamics. Part I: characterization of platelet hydrodynamic collisions and wall effects. Biophys J 2008; 95: 2539–2555
   PubMed Web of Science ®Google Scholar
• Mody NA, King MR. Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbα-vWF-GPIbα bridging. Biophys J 2008; 95: 2556–2574
   Google Scholar
• Mohri H, Yoshioka A, Zimmerman TS, Ruggeri ZM. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen, and characterization of its three distinct functional sites. J Biol Chem 1989; 264: 17361–17367
   PubMed Web of Science ®Google Scholar
• Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440–1445
   PubMed Web of Science ®Google Scholar
• Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: involvement of glycoprotein VI in the platelet adhesion. Blood 1996; 88: 2081–2092
   PubMed Web of Science ®Google Scholar
• Nanda N, Andre P, Bao M, Clauser K, DeGuzman F, Howle D, Conley PB, Terhorst C, Phillips DR. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 2005; 106: 3028–3034
   PubMed Web of Science ®Google Scholar
• Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ. Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem 2005; 280: 24680–24689
   PubMed Web of Science ®Google Scholar
• Nesbitt WS, Giuliano S, Kulkarni S, Dopheide SM, Harper IS, Jackson SP. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol 2003; 160: 1151–1161
   PubMed Web of Science ®Google Scholar
• Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385–392
   PubMed Web of Science ®Google Scholar
• Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003; 100: 2415–2419
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fñssler R. Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20: 2120–2130
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003; 102: 449–461
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985; 318: 470–472
   PubMed Web of Science ®Google Scholar
• Nigatu A, Sime W, Gorfu G, Geberhiwot T, Anduren I, Ingerpuu S, Doi M, Tryggvason K, Hjemdhal P, Patarroyo M. Megakaryocytic cells synthesize and platelets secrete α5-laminins, and the endothelial laminin isoform laminin 10 (α5β1γ1) strongly promotes adhesion but not activation of platelets. Thromb Haemost 2007; 95: 85–93
   Google Scholar
• Nishida N, Sumikawa H, Sakakura M, Shimba N, Takahashi H, Terasawa H, Suzuki EI, Shimada I. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment. Nat Struct Biol 2003; 10: 53–58
   Google Scholar
• Pareti FI, Niiya K, McPherson JM, Ruggeri ZM. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 1987; 262: 13835–13841
   PubMed Web of Science ®Google Scholar
• Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625–628
   PubMed Web of Science ®Google Scholar
• Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, Ye F, Tiedt R, Skoda RC, Monkley SJ, Critchley DR, Ginsberg MH. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 2007; 204: 3103–3111
   PubMed Web of Science ®Google Scholar
• Prevost N, Woulfe DS, Jiang H, Stalker TJ, Marchese P, Ruggeri ZM, Brass LF. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 2005; 102: 9820–9825
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Ann Rev Biochem 1995; 64: 403–434
   PubMed Web of Science ®Google Scholar
• Rand JH, Patel ND, Schwartz E, Zhou S, Potter BJ. 150-kd von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1991; 88: 253–259
   PubMed Web of Science ®Google Scholar
• Rand JH, Sussman II, Gordon RE, Chu SV, Solomon V. Localization of factor-VIII-related antigen in human vascular subendothelium. Blood 1980; 55: 752–756
   PubMed Web of Science ®Google Scholar
• Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, Freedman J, Ni H. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005; 3: 875–883
   PubMed Web of Science ®Google Scholar
• Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, Bai X, Gross PL, Freedman J, Ni H. (2008). Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood First Edition Paper, prepublished online November 25, 2008; DOI 2010.1182/blood-2008-2004-148361.
   Google Scholar
• Ribba AS, Loisel I, Lavergne JM, Juhan-Vague I, Obert B, Cherel G, Meyer D, Girma JP. Ser968thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001; 86: 848–854
   PubMed Web of Science ®Google Scholar
• Ribes JA, Francis CW. Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin. Blood 1990; 75: 1460–1465
   Google Scholar
• Roberts DD, Williams SB, Gralnick HR, Ginsburg V. von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem 1986; 261: 3306–3309
   Google Scholar
• Romijn RA, Westein E, Bouma B, Schiphorst ME, Sixma JJ, Lenting PJ, Huizinga EG. Mapping the collagen-binding site in the von Willebrand factor-A3 domain. J Biol Chem 2003; 278: 15035–15039
   Google Scholar
• Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190: 803–814
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227–1234
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. von Willebrand factor. Curr Opin Hematol 2003; 10: 142–149
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Type iib von Willebrand disease: a paradox explains how von Willebrand works. J Thromb Haemost 2004; 2: 2–6
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Bader R, De Marco L. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci USA 1982; 79: 6038–6041
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 1–12
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 94: 172–178
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100: 1673–1685
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006; 108: 1903–1910
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980; 302: 1047–1051
   PubMed Web of Science ®Google Scholar
• Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemost 2006; 4: 2103–2114
   PubMed Web of Science ®Google Scholar
• Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII/von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636–638
   PubMed Web of Science ®Google Scholar
• Santoro SA. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochim Biophys Acta 1983; 756: 123–126
   PubMed Web of Science ®Google Scholar
• Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913–920
   PubMed Web of Science ®Google Scholar
• Sarratt KL, Chen H, Zutter MM, Santoro SA, Hammer DA, Kahn ML. GPVI and α2β1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005; 106: 1268–1277
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657–666
   PubMed Web of Science ®Google Scholar
• Savage B, Ginsberg MH, Ruggeri ZM. Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 1999; 94: 2704–2715
   PubMed Web of Science ®Google Scholar
• Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289–297
   PubMed Web of Science ®Google Scholar
• Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA 2002; 99: 425–430
   PubMed Web of Science ®Google Scholar
• Sawada Y, Fass DN, Katzmann JA, Bahn RC, Bowie EJ. Hemostatic plug formation in normal and von Willebrand pigs: the effect of the administration of cryoprecipitate and a monoclonal antibody to Willebrand factor. Blood 1986; 67: 1229–1239
   Google Scholar
• Schmid-Schönbein H, Born GVR, Richardson PD, Cusack N, Rieger H, Forst R, Rohling-Winkel I, Blasberg P, Wehmeyer A. Rheology of thrombotic processes in flow: the interaction of erythrocytes and thrombocytes subjected to high flow forces. Biorheology 1981; 18: 415–444
   Google Scholar
• Schneppenheim R, Budde U. Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update. Semin Hematol 2005; 42: 15–28
   Google Scholar
• Schulze H, Shivdasani RA. Mechanisms of thrombopoiesis. J Thromb Haemost 2005; 3: 1717–1724
   PubMed Web of Science ®Google Scholar
• Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood 2003; 101: 2637–2645
   PubMed Web of Science ®Google Scholar
• Siediecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939–2950
   PubMedGoogle Scholar
• Siegel JM, Markou CP, Ku DN, Hanson SR. A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng 1994; 116: 446–451
   PubMed Web of Science ®Google Scholar
• Simon DI, Chen Z, Xu H, Li CQ, Dong JF, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (cd11b/cd18). J Exp Med 2000; 192: 193–204
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Harker LS. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Hematol 1978; 7: 523–538
   PubMedGoogle Scholar
• Smyth SS, Reis ED, Vaananen H, Zhang W, Coller BS. Variable protection of β3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood 2001; 98: 1055–1062
   PubMedGoogle Scholar
• Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest 1991; 87: 1787–1793
   PubMed Web of Science ®Google Scholar
• Sobel M, Soler DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 1992; 267: 8857–8862
   PubMed Web of Science ®Google Scholar
• Soslau G, Prest PJ, Class R, George R, Paladino F, Violetta G. Comparison of sea turtle thrombocyte aggregation to human platelet aggregation in whole blood. Compar Biochem Physiol B Biochem Mol Biol 2005; 142: 353–360
   Google Scholar
• Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 85–90
   PubMed Web of Science ®Google Scholar
• Tangelder GJ, Slaaf DW, Arts T, Reneman RS. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol 1988; 254: H1059–H1064
   PubMedGoogle Scholar
• Tran H, Tanaka A, Litvinovich SV, Medved LV, Haudenschild CC, Argraves WS. The interaction of fibulin-1 with fibrinogen: a potential role in hemostasis and thrombosis. J Biol Chem 1995; 270: 19458–19464
   PubMed Web of Science ®Google Scholar
• Turitto VT, Baumgartner HR. Effect of physical factors on platelet adherence to subendothelium. Thromb Diath Haemorrh 1974; 60: 17–24
   Google Scholar
• Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res 1975; 9: 335–344
   PubMed Web of Science ®Google Scholar
• Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823–831
   PubMed Web of Science ®Google Scholar
• Ulrichts H, Vanhoorelbeke K, Girma JP, Lenting PJ, Vauterin S, Deckmyn H. The von Willebrand factor self-association is modulated by a multiple domain interaction. J Thromb Haemost 2005; 3: 552–561
   Google Scholar
• van Breugel HHFI, de Groot PG, Heethaar RM, Sixma JJ. Role of plasma viscosity in platelet adhesion. Blood 1992; 80: 953–959
   Google Scholar
• Wagner DD. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70: 105–110
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Atertio Thromb Vasc Biol 2003; 23: 2131–2137
   PubMed Web of Science ®Google Scholar
• Wang SK, Hwang NHC. On transport of suspended particulates in tube flow. Biorheology 1992; 29: 353–377
   Google Scholar
• Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628–635
   PubMed Web of Science ®Google Scholar
• Weiss HJ. Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med 1975; 293: 531–541
   PubMed Web of Science ®Google Scholar
• Weiss HJ. Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med 1975; 293: 580–588
   PubMedGoogle Scholar
• Weiss HJ, Rogers J. Fibrinogen and platelets in the primary arrest of bleeding-studies in two patients with congenital afibrinogenemia. N Engl J Med 1971; 285: 369–374
   Google Scholar
• Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate–dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978; 92: 750–764
   PubMed Web of Science ®Google Scholar
• Wencel-Drake JD, Painter RG, Zimmerman TS, Ginsberg MH. Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section. Blood 1985; 65: 929–938
   PubMed Web of Science ®Google Scholar
• Werneck CC, Vicente CP, Weinberg JS, Shifren A, Pierce RA, Broekelmann TJ, Tollefsen DM, Mecham RP. Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury. Blood 2008; 111: 4137–4144
   Google Scholar
• Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004; 30: 491–498
   PubMed Web of Science ®Google Scholar
• Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, Deckmyn H. Inhibition of the von Willebrand (VWF)-collagen interaction by an anti-human VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood 2002; 99: 3623–3628
   PubMed Web of Science ®Google Scholar
• Yago T, Lou J, Wu T, Yang J, Miner JJ, Coburn L, Lopez JA, Cruz MA, Dong JF, McIntire LV, McEver RP, Zhu C. Platelet glycoprotein Ibα forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 2008; 118: 3195–3207
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Akamatsu N, Yamazaki H, Tanoue K. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol 1992; 81: 86–92
   PubMed Web of Science ®Google Scholar
• Yanai H, Chiba H, Fujiwara H, Morimoto M, Abe K, Yoshida S, Takahashi Y, Fuda H, Hui SP, Akita H, Kobayashi K, Matsuno K. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000; 84: 436–441
   Google Scholar